Ninth Circuit revives trade secrets claims in DNA-sequencing spat

Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter “reasonable particularity” rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

How Inhibrx defended a $450m damages suit

16 December 2024 A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares insights into the defence strategy that led to the win.

Big Pharma

Life sciences trade secrets: emerging trends

5 July 2023 With competition, employee mobility and chatbots all on the rise, protecting IP as trade secrets has never been more important for life sciences firms, says Anthony Fitzpatrick of Duane Morris.

Americas

Illumina escapes genetics trade secrets claims

17 January 2020 A US judge has thrown out a lawsuit accusing US biotechnology companies Illumina and Affymetrix of a “complex, multi-decade concerted effort” to conceal the theft of trade secrets in the 1990s.

More features

A second bite at the Apple: Adjudicating redesigns after an ITC exclusion order

Less is more: patent lawyers flip the script after Amgen

‘Doing more with less’: In-house counsel on budgets and strategy

End of the ‘Death Squad’? Squires puts PTAB on trial

Data and delivery: Inside AI's inventorship dilemma

Weil continues expansion with top trade secrets litigator

Top pharma, biotech, and medtech experts gather at LSPN Fall

Mitsubishi Tanabe doubles down on Radicava protection

Ninth Circuit revives trade secrets claims in DNA-sequencing spat

More on this story

Editor's picks

Editor's picks

More features